National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Eptifibatide
Synonyms

Eptifibatide

EPTIFIBATIDE

L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophy-L-prolyl-, cyclic(1-6)-disulfide

Integrilin

Definitions

A cyclical heptapeptide with anticoagulant activity. Eptifibatide selectively and reversibly binds to and blocks the platelet glycoprotein IIb/IIIa receptor. This prevents the binding of fibrinogen, von Willebrand factor, and other adhesive ligands and leads to an inhibition of platelet aggregation and prevents thrombus development.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47516

CAS_Registry

148031-34-9

188627-80-7

CHEBI_ID

CHEBI:291902

Chemical_Formula

C35H49N11O9S2

code

C47516

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C201600

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

Contributing_Source

FDA

HemOnc

DEFINITION

A cyclical heptapeptide with anticoagulant activity. Eptifibatide selectively and reversibly binds to and blocks the platelet glycoprotein IIb/IIIa receptor. This prevents the binding of fibrinogen, von Willebrand factor, and other adhesive ligands and leads to an inhibition of platelet aggregation and prevents thrombus development.

FDA_UNII_Code

NA8320J834

FULL_SYN

Eptifibatide

EPTIFIBATIDE

L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophy-L-prolyl-, cyclic(1-6)-disulfide

Integrilin

label

Eptifibatide

Legacy Concept Name

Eptifibatide

Preferred_Name

Eptifibatide

prefixIRI

Thesaurus:C47516

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C0253563

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1327

Delete Subject Author Type Created
No notes to display
Create mapping

Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_291902 DRON LOOM
http://www.semanticweb.org/admin/ontologies/2022/7/MIO:02157 MIO LOOM
http://purl.bioontology.org/ontology/LNC/LP171395-9 LOINC LOOM
http://purl.bioontology.org/ontology/NDDF/007557 NDDF LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148569 NDFRT LOOM
http://purl.bioontology.org/ontology/ATC/B01AC16 ATC LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0253563 OCHV LOOM
http://www.phoc.org.cn/pmo/class/PMO_00025412 PMAPP-PMO LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#25190 OCHV LOOM
http://purl.bioontology.org/ontology/VANDF/4021114 VANDF LOOM
http://www.drugbank.ca/drugs/DB00063 FTC LOOM
http://www.co-ode.org/ontologies/galen#Eptifibatide GALEN LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/386998009 SNOMEDCT LOOM
http://mimi.case.edu/ontologies/2009/9/DrugOntology#eptifibatide SDO LOOM
http://purl.bioontology.org/ontology/MESH/D000077542 MESH LOOM
https://go.drugbank.com/drugs/DB00063 MDM LOOM
http://purl.obolibrary.org/obo/CHEBI_291902 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_291902 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_291902 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_291902 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_291902 DDSS LOOM
http://purl.obolibrary.org/obo/CHEBI_291902 BIOMODELS LOOM
http://purl.bioontology.org/ontology/RXNORM/75635 RXNORM LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C086648 RH-MESH LOOM
http://purl.obolibrary.org/obo/NCIT_C47516 BERO LOOM